New England Private Wealth Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
New England Private Wealth Advisors's ARKG Position: Q4 2024 in Review
New England Private Wealth Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2024, closing a stake of 11,496 shares — an estimated $294K sold.
New England Private Wealth Advisors first reported a position in ARKG in Q2 2020 and held it in 18 quarters. The position peaked at $1.09M in Q2 2021. 238 funds tracked by Wall St. Rank hold ARKG as of Q4 2024.
- New England Private Wealth Advisors reported no remaining ARK Genomic Revolution ETF position as of Q4 2024 after selling out during the quarter.
- New England Private Wealth Advisors sold 11,496 ARK Genomic Revolution ETF shares in Q4 2024, an estimated $294K.
- New England Private Wealth Advisors first reported a position in ARK Genomic Revolution ETF in Q2 2020 and held it in 18 quarters.
- New England Private Wealth Advisors's ARK Genomic Revolution ETF position peaked at $1.09M in Q2 2021.
- 238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2024.
Based on New England Private Wealth Advisors's 13F filing for Q4 2024, filed 7 Feb 2025.